F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis

Clinical Nuclear Medicine

Volumn 35, Issue 2, 2010, Pages 67-70

  Kim, Seok Ki ^a   Im, Hyung Jun ^a   Kim, Woojun ^a   Kim, Tae Sung ^a   Hwangbo, Bin ^a   Kim, Ho Jin ^a  

^a National Cancer Center   (South Korea)

Author keywords

F 18 FDG; F 18 FLT; Mediastinum; Neurosarcoidosis; PET CT

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHEST TIGHTNESS; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; HYPERALGESIA; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RELAPSE; REMISSION; SARCOIDOSIS; SPINAL CORD DISEASE; WHOLE BODY PET;

ADULT; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; SARCOIDOSIS; THYMIDINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76149101941     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181c7c149     Document Type: Article

References (19)

1. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997;157:1864-1868.
2. Joseph FG, Scolding NJ. Sarcoidosis of the nervous system. Pract Neurol. 2007;7:234-244.
3. Spencer TS, Campellone JV, Maldonado I, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum. 2005;34:649-661.
4. Prabhakar HB, Rabinowitz CB, Gibbons FK, et al. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. Am J Roentgenol. 2008;190: S1-S6.
5. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the F-18 FDG PET literature. J Nucl Med. 2001;42:S1-S93.
6. Love C, Tomas MB, Tronco GG, et al. FDG PET of infection and inflammation. RadioGraphics. 2005;25:1357-1368.
7. Zhuang H, Alavi A. 18-Flurodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
8. Dubey N, Miletich RS, Wasay M, et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci. 2002;205:77-81.
9. Lewis P, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1647-1649.
10. Bakheet SM, Powe J, Ezzat A, et al. F-18-FDG uptake in tuberculosis. Clin Nucl Med. 1998;23:739-742.
11. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47:1571-1576.
12. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [18F] FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
13. Buck AK, Bommer M, Stilgenbauer S, et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res. 2006;66:11055-11061.
14. Francis DL, Freeman A, Visvikis D, et al. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut. 2003;52:1602-1606.
15. Van Westreenen HL, Cobben DC, Jager PL, et al. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. J Nucl Med. 2005;46:400-404.
16. Buck AK, Halter G, Schirrmeister H, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44:1426-1431.
17. Dittmann H, Dohmen BM, Paulsen F, et al.[18F]FLT PET for diagnosis and staging of thoracic tumours. Eur J Nucl Med Mol Imaging. 2003;30:1407-1412.
18. Van Waarde A, Cobben DCP, Suurmeijer AJH, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a Rodent Model. J Nucl Med. 2004;45:695-700.
19. Van Der Gaag RD, Van Maarsseveen AC, Broekhuizen-Davies JM, et al. Application of in-vitro techniques to determine proliferation in human sarcoid lymph nodes. J Pathol. 2005;139:239-245.